Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
This study is currently recruiting participants.
Verified October 2012 by National Taiwan University Hospital
Study NCT01163435   Information provided by National Taiwan University Hospital

First Received on July 1, 2010.   Last Updated on October 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Helicobacter Infection
Additional conditions recognized in this trial
Helicobacter Infections
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Interventions listed in this trial
high dose dual therapy
sequential therapy
clarithromycin-based triple therapy
levofloxacin-based triple therapy
Additional drug interventions recognized in this trial
Amoxicillin
Clarithromycin
Ofloxacin
Rabeprazole
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protein Synthesis Inhibitors
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
National Taiwan University Hospital
National Science Council, Taiwan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services